Although Divorce is a unique respective episode in each couple’s lives, there are many who attempt to seek an answer for trends among different populations. In the end, it’s the specific psychology of and between the partners that determines each Split.
FOR IMMEDIATE RELEASE
Contact: CMS Media Relations Group
June 28, 2011
Affordable Care Act Delivers Cheaper Prescription Drugs to Nearly 500,000 People
Law Has Already Saved $260 Million, Averaging $545 for People in Donut Hole
Thanks to the Affordable Care Act, nearly 500,000 people with Medicare Part D
who reached the gap in coverage know as the donut hole have received an
automatic 50 percent discount on their covered brand name prescription drugs.
The Centers for Medicare & Medicaid Services (CMS) posted data today that shows
478,272 Medicare beneficiaries have benefitted from the 50 percent discount in
the first five months of 2011. These beneficiaries saved a total of
$260,534,102, or an average savings of $545 per beneficiary.
The number of seniors benefiting from this discount continues to grow. In the
month of May alone, the total number of beneficiaries who received the discount
rose by over 76 percent, while the dollar amount of savings rose by over 56
percent. Based on data from past years, CMS expects that as many as 4 million
additional beneficiaries will fall into the coverage gap later this year and
benefit from these discounts.
Most of these discounts are helping Americans with serious medical conditions
nearly 14 percent of the benefits provided to date more than $36 million are
for cancer drugs, more than 8 percent or $21 million for drugs to help control
high blood pressure and cholesterol, and another more than 7 percent about $20
million are for drugs provides to diabetic patients.
"Without the Affordable Care Act, many seniors and people with disabilities
would pay twice as much for their prescription drugs in the donut hole," said
CMS Administrator Donald M. Berwick, M.D. "People on Medicare will now be able
to better afford their medicine, and these discounts will continue as coverage
in the gap grows until the donut hole is closed."
A November 2010 analysis by the U.S. Department of Health and Human Services
estimated that Medicare improvements in the Affordable Care Act would provide
average savings for those enrolled in traditional Medicare totaling more than
$3,500 over the next 10 years, with even higher average savings of as much as
$12,300 for those with higher drug costs.
For more information on how the prescription drug discount and other provisions
of the Affordable Care Act benefits seniors and people with disabilities, visit
A blog and state-by-state numbers are up on healthcare.gov now at:
It seems that Americans are in the midst of a raging epidemic of mental illness, at least as judged by the increase in the numbers treated for it. The tally of those who are so disabled by mental disorders that they qualify for Supplemental Security Income (SSI) or Social Security Disability Insurance (SSDI) increased nearly two and a half times between 1987 and 2007—from one in 184 Americans to one in seventy-six. For children, the rise is even more startling—a thirty-five-fold increase in the same two decades. Mental illness is now the leading cause of disability in children, well ahead of physical disabilities like cerebral palsy or Down syndrome, for which the federal programs were created.
A large survey of randomly selected adults, sponsored by the National Institute of Mental Health (NIMH) and conducted between 2001 and 2003, found that an astonishing 46 percent met criteria established by the American Psychiatric Association (APA) for having had at least one mental illness within four broad categories at some time in their lives. The categories were “anxiety disorders,” including, among other subcategories, phobias and post-traumatic stress disorder (PTSD); “mood disorders,” including major depression and bipolar disorders; “impulse-control disorders,” including various behavioral problems and attention-deficit/hyperactivity disorder (ADHD); and “substance use disorders,” including alcohol and drug abuse. Most met criteria for more than one diagnosis. Of a subgroup affected within the previous year, a third were under treatment—up from a fifth in a similar survey ten years earlier.
Nowadays treatment by medical doctors nearly always means psychoactive drugs, that is, drugs that affect the mental state. In fact, most psychiatrists treat only with drugs, and refer patients to psychologists or social workers if they believe psychotherapy is also warranted. The shift from “talk therapy” to drugs as the dominant mode of treatment coincides with the emergence over the past four decades of the theory that mental illness is caused primarily by chemical imbalances in the brain that can be corrected by specific drugs. That theory became broadly accepted, by the media and the public as well as by the medical profession, after Prozac came to market in 1987 and was intensively promoted as a corrective for a deficiency of serotonin in the brain. The number of people treated for depression tripled in the following ten years, and about 10 percent of Americans over age six now take antidepressants. The increased use of drugs to treat psychosis is even more dramatic. The new generation of antipsychotics, such as Risperdal, Zyprexa, and Seroquel, has replaced cholesterol-lowering agents as the top-selling class of drugs in the US.
What is going on here? Is the prevalence of mental illness really that high and still climbing? Particularly if these disorders are biologically determined and not a result of environmental influences, is it plausible to suppose that such an increase is real? Or are we learning to recognize and diagnose mental disorders that were always there? On the other hand, are we simply expanding the criteria for mental illness so that nearly everyone has one? And what about the drugs that are now the mainstay of treatment? Do they work? If they do, shouldn’t we expect the prevalence of mental illness to be declining, not rising?
It is No surprise that, as Corporate Profiteers sought out Medicine as the New Commodity, there was a complimentary rise in Mental “Illness”, Pharmaceutical Research on Mental “Illness” and Managed Care Health Insurance.
The FDA’s Kessler, when the Head, was adamantly against Direct Advertising of Pharmaceuticals to Consumers. Interestingly, once becomming a “Consultant” to the Industry, we are inundated with Majik Pillz for just about every discontent imaginable.
Every Generation has their Pet Prescriptions for general society’s emotional laments. But, the general public has no idea of the complexities of the capacity of the human mind and all it’s various states. Nor are they aware that the “Medical Model” of “Diagnosis” is but One way of assessing an individuals feelings and perceptions at any time.
We need Illegal Drugs to continue to flow into this country, not because of the “Demand”, but because of economic dependence on the Industry of Drug Enforcement and Treatment. And So …. Rejoice in your Mental “Illness” Symptoms, your “Emotional Diseases” … you play an important part in supporting our New Economy.